review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Philip F Halloran | Q40000948 |
P2093 | author name string | P F Halloran | |
P2860 | cites work | Molecular signatures distinguish human central memory from effector memory CD8 T cell subsets | Q28278055 |
Heterologous immunity provides a potent barrier to transplantation tolerance | Q35095576 | ||
Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction | Q36135190 | ||
Antigen presentation by human microvascular endothelial cells triggers ICAM-1-dependent transendothelial protrusion by, and fractalkine-dependent transendothelial migration of, effector memory CD4+ T cells | Q36731726 | ||
Vascular endothelial cells have impaired capacity to present immunodominant, antigenic peptides: a mechanism of cell type-specific immune escape. | Q40460760 | ||
Interferon-gamma acts directly on rejecting renal allografts to prevent graft necrosis | Q42856697 | ||
IFN-gamma alters the pathology of graft rejection: protection from early necrosis | Q43628918 | ||
Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. | Q53521493 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1126-1134 | |
P577 | publication date | 2010-03-23 | |
P1433 | published in | American Journal of Transplantation | Q4744273 |
P1476 | title | T cell-mediated rejection of kidney transplants: a personal viewpoint | |
P478 | volume | 10 |
Q40278935 | Allo-HLA Cross-Reactivities of Cytomegalovirus-, Influenza-, and Varicella Zoster Virus-Specific Memory T Cells Are Shared by Different Healthy Individuals |
Q50936985 | Alloimmune T cells in transplantation. |
Q39829568 | An Integrated View of Molecular Changes, Histopathology and Outcomes in Kidney Transplants |
Q100408260 | Angiotensin II type 1 receptor antibodies in kidney transplantation: An evidence-based comprehensive review |
Q38813562 | Antitumor Activity of Total Flavonoids from Daphne genkwa in Colorectal Cancer |
Q41634812 | Belatacept-based, ATG-Fresenius-induction regimen for kidney transplant recipients: a proof-of-concept study |
Q42059394 | Bidirectional intragraft alloreactivity drives the repopulation of human intestinal allografts and correlates with clinical outcome. |
Q35758302 | Bβ(15-42) attenuates the effect of ischemia-reperfusion injury in renal transplantation |
Q40967497 | Chronic rejection: Differences and similarities in various solid organ transplants |
Q48006232 | Comprehensive Analysis of Transcript Changes Associated With Allograft Rejection: Combining Universal and Selective Features. |
Q35995043 | Derivation and validation of a cytokine-based assay to screen for acute rejection in renal transplant recipients |
Q39513942 | Detection of Virus-Specific CD8+ T Cells With Cross-Reactivity Against Alloantigens: Potency and Flaws of Present Experimental Methods |
Q34746535 | Differential effects of activated human renal epithelial cells on T-cell migration |
Q35541507 | Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis |
Q37798988 | Genomics in human renal transplantation |
Q24305497 | Human renal tubular epithelial cells suppress alloreactive T cell proliferation |
Q42740954 | Impact of acute rejection on kidney allograft outcomes in recipients on rapid steroid withdrawal |
Q45913402 | Inhibition of intimal hyperplasia in murine aortic allografts by administration of a small-molecule TLR4 inhibitor TAK-242. |
Q53181446 | Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsies. |
Q30414748 | MicroRNAs as biomarkers in solid organ transplantation |
Q47842670 | Minor H antigen matches and mismatches are equally distributed among recipients with or without complications after HLA identical sibling renal transplantation |
Q46363554 | Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies |
Q64118286 | Natural Killer Cells in Kidney Health and Disease |
Q38228279 | Neutrophil gelatinase-associated lipocalin: ready for routine clinical use? An international perspective. |
Q55373359 | One-year Allograft and Patient Survival in Renal Transplant Recipients Receiving Antiplatelet Therapy at the Time of Transplantation. |
Q86779666 | Post-transplant soluble CD30 levels are associated with early subclinical rejection in kidney transplantation |
Q42279035 | Potential impact of microarray diagnosis of T cell-mediated rejection in kidney transplants: The INTERCOM study |
Q40289674 | Precision Subtypes of T Cell-Mediated Rejection Identified by Molecular Profiles |
Q36238316 | Soothing touch of CD31 protects endothelium during cellular immune responses |
Q94016517 | Specialized Roles of Human Natural Killer Cell Subsets in Kidney Transplant Rejection |
Q92525927 | Suppressor of cytokine signaling genes in renal transplant receivers: Association with transplant fate |
Q39395411 | Systems biology approach to transplant tolerance: proof of concept experiments using RNA interference (RNAi) to knock down hub genes in Jurkat and HeLa cells in vitro |
Q98465673 | The Role of Natural Killer Cells in the Immune Response in Kidney Transplantation |
Q36782862 | The Use of Genomics and Pathway Analysis in Our Understanding and Prediction of Clinical Renal Transplant Injury |
Q39812222 | The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course. |
Q38247690 | The significance of histological diagnosis in renal allograft biopsies in 2014. |
Q50743724 | Using Molecular Phenotyping to Guide Improvements in the Histologic Diagnosis of T Cell-Mediated Rejection. |
Search more.